Perrigo (PRGO) vs Schrodinger (SDGR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Schrodinger (SDGR) has outperformed Perrigo (PRGO) over the past year, gaining 35.4% versus a loss of 32.9%. Over five years, SDGR leads with a -50.7% price change compared with -67.5% for PRGO. Schrodinger is the larger company by market cap ($2.04 billion vs $2.01 billion), about 1.0 times the size.
Perrigo pays a dividend yielding 7.97%, while Schrodinger does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PRGO | SDGR |
|---|---|---|
| Share price | $14.55 | $27.29 |
| Market cap | $2.01B | $2.04B |
| 1-day change | +3.93% | -5.57% |
| YTD return | +4.53% | +52.63% |
| 1-year return | -32.89% | +35.37% |
| 5-year return | -67.46% | -50.70% |
| Forward P/E | 6.07 | — |
| EPS (TTM) | $-12.28 | $-0.74 |
| Dividend yield | 7.97% | 0.00% |
| Annual dividend | $1.16 | $0.00 |
| 52-week high | $22.02 | $33.78 |
| 52-week low | $9.23 | $10.95 |
| Distance from 52-week high | -33.92% | -19.21% |
| Analyst consensus | none | none |
| Avg. price target upside | +13.40% | -21.47% |
| Average volume | 2.81M | 1.69M |
| Shares outstanding | 138.37M | 65.64M |
| Employees | 8,100 | 850 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SDGR has outperformed PRGO by 68.3 percentage points over the past year.
- Perrigo offers a meaningfully higher dividend yield (7.97% vs 0.00%).
About Perrigo
PRGO stock →Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments.
Health Care · Biotechnology: Pharmaceutical Preparations · 8,100 employees
About Schrodinger
SDGR stock →Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery.
Health Care · Biotechnology: Pharmaceutical Preparations · 850 employees
PRGO vs SDGR FAQ
Which is bigger, Perrigo or Schrodinger?
Schrodinger (SDGR) is larger, with a market capitalization of $2.04B compared with $2.01B for Perrigo (PRGO).
Which stock has performed better over the past year, PRGO or SDGR?
SDGR returned +35.37% over the past 12 months, compared with -32.89% for PRGO (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Perrigo or Schrodinger?
Perrigo pays a dividend yielding 7.97%, while Schrodinger does not currently pay a regular dividend.
Are Perrigo and Schrodinger in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.